Samantha is a Partner at Elaia, the European venture firm backing deep-tech and disruptive business models, where she leads investments in digital life sciences/HealthTech. She started her career as a consultant at Eurogroup, focusing on organisation and strategy for Banking & Finance, before moving to Clipperton Finance, a corporate finance advisory dedicated to high-growth technology companies. At Elaia, Samantha has backed and supported several innovative health companies including Doccla, Inato, Sim&Cure, and Inheart that use advanced technologies to improve patient care and clinical outcomes. She works closely with founders from seed through scale-up on strategy, data/AI, go-to-market, and fundraising. Samantha also serves on the board of France Digitale, the European association uniting tech entrepreneurs and investors.